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LRIG proteins regulate lipid metabolism via BMP
signaling and affect the risk of type 2 diabetes
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Håkan Hedman 1✉
Leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins have been implicated
as regulators of growth factor signaling; however, the possible redundancy among mam-
malian LRIG1, LRIG2, and LRIG3 has hindered detailed elucidation of their physiological
functions. Here, we show that Lrig-null mouse embryonic fibroblasts (MEFs) are deficient in
adipogenesis and bone morphogenetic protein (BMP) signaling. In contrast, transforming
growth factor-beta (TGF-β) and receptor tyrosine kinase (RTK) signaling appeared unaltered
in Lrig-null cells. The BMP signaling defect was rescued by ectopic expression of LRIG1 or
LRIG3 but not by expression of LRIG2. Caenorhabditis elegans with mutant LRIG/sma-10 var-
iants also exhibited a lipid storage defect. Human LRIG1 variants were strongly associated
with increased body mass index (BMI) yet protected against type 2 diabetes; these effects
were likely mediated by altered adipocyte morphology. These results demonstrate that LRIG
proteins function as evolutionarily conserved regulators of lipid metabolism and BMP sig-
naling and have implications for human disease.
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The mammalian leucine-rich repeats and immunoglobulin-like domains (LRIG/Lrig) protein family consists of threetransmembrane proteins, LRIG1, LRIG2, and LRIG31. The
three mammalian LRIG paralogs appear to have both distinct and
redundant functions, which is evident during mouse develop-
ment2. Because Lrig-null (i.e., Lrig1-/-;Lrig2-/-;Lrig3-/-) mice
are not viable, molecular investigations regarding the functions
of the mammalian LRIG proteins have been hampered. Never-
theless, numerous reports have indicated that LRIG proteins
are important etiological and prognostic factors in cancer3,4.
In most cases, these roles have been attributed to the ability of
LRIG1 to negatively regulate various receptor tyrosine kinases
(RTKs)5,6,7,8,9,10,11. However, in the nematode Caenorhabditis
elegans (C. elegans), the sole LRIG homolog, SMA-10, regulates
body size by promoting bone morphogenetic protein (BMP)
signaling12,13. Whether the mammalian LRIG proteins also reg-
ulate BMP signaling remains to be investigated.
The BMP signaling system is evolutionarily conserved and
regulates major developmental and homeostatic processes14–16.
The BMP families of cytokines and their receptors belong to the
transforming growth factor-beta (TGF-β) and TGF-β receptor
superfamilies, respectively. The human genome encodes at least
20 BMP ligands, three BMP type 1 receptors, and three type 2
receptors15,17–19. Upon ligand binding, the constitutively active
type 2 receptor phosphorylates and activates an associated type 1
receptor, which, in turn, phosphorylates the downstream signal-
ing mediators SMAD1, SMAD5, and SMAD815. The phos-
phorylated SMAD1/5/8 complex then recruits the co-SMAD
SMAD4 and is translocated into the nucleus, where it regulates
expression of BMP-responsive genes20. In addition to the SMAD-
mediated signaling pathway, BMPs may also initiate SMAD-
independent signaling, including the activation of the MAP
kinases ERK1/2, p38, and JNK21,22. Furthermore, BMP signaling
is fine-tuned by regulatory proteins that either enhance or sup-
press signaling15,20,23. Although the BMP system has been
extensively studied for decades, novel regulators and key signaling
proteins may still await discovery.
Obesity constitutes a global epidemic and is a major risk factor
for several conditions, including insulin resistance, type 2 dia-
betes, heart disease, and several forms of cancer24–26. Adipose
tissue serves as a key regulator of energy homeostasis in
humans27. Adipose tissue can expand in volume either by
enlarging adipocyte size (hypertrophy) or by adipocyte pro-
liferation (hyperplasia). Of these two processes, adipocyte
hypertrophy is associated with an unfavorable metabolic profile,
whereas hyperplasia may improve metabolic homeostasis due to
the increased number of insulin-sensitive cells27,28. Adipocyte
differentiation involves the sequential commitment of mesench-
ymal stem cells to preadipocytes followed by their numerical
expansion and terminal differentiation into adipocytes29,30. In
this process, BMP signaling is involved in the commitment of
mesenchymal stem cells into preadipocytes30,31, as well as in the
choice between white or brown/beige adipocyte differentiation
and adipocyte size32. C. elegans, on the other hand, lacks dedi-
cated adipocytes;33 however, evidence suggests that BMP signal-
ing may also regulate lipid accumulation in the lipid-storing
intestinal cells of C. elegans34,35. In mice, Lrig3-deficient animals
display altered plasma lipid levels36. However, a direct link
between LRIG or SMA-10 proteins and adipogenesis, lipid
metabolism, or type 2 diabetes has not yet been studied.
In the present study, we generated Lrig-null mouse embryonic
fibroblasts (MEFs) to analyze the physiological and molecular
functions of LRIG proteins in isogenic cells, without the possibly
confounding expression of endogenous LRIG proteins. By
exploiting these cells, we demonstrated that mammalian LRIG
proteins regulate adipogenesis and sensitize cells to low
concentrations of BMPs. We also analyzed the sma-10/LRIG
mutant C. elegans and showed that LRIG also regulates fat
accumulation in the worm. Finally, we investigated possible
associations between LRIG1 single nucleotide polymorphisms
(SNPs) and human metabolic traits and revealed a striking dis-
cordant association between common LRIG1 variants, a reduced
risk of type 2 diabetes, and an increased body mass index (BMI),
which we showed was likely mediated by adipocyte morphology.
Results
Generation and characterization of Lrig-null MEFs. To inves-
tigate the molecular functions of Lrig proteins, we generated Lrig-
null cell lines by immortalizing MEFs that carried floxed Lrig1,
Lrig2, and Lrig3 alleles, followed by gene ablation via cell trans-
duction with Cre recombinase-expressing adenoviruses. Thereby,
we created four Lrig-null (herein also called Lrig triple knockout;
TKO) MEF lines (TKO1-4) together with four corresponding
wild-type control MEF lines (WT1-4). The stable ablation of
Lrig1, Lrig2, and Lrig3 was confirmed by polymerase chain
reaction (PCR) genotyping (Supplementary Fig. 1a), Western
blotting (Supplementary Fig. 1b), and a sensitive duplex droplet
digital PCR (ddPCR) assay (Supplementary Table 1). With the
ddPCR assay, the fraction of contaminating wild-type MEFs in
the Lrig-null populations was analyzed by quantifying the relative
gene copy numbers of the targeted Lrig3 exon 1 versus a reference
locus. This analysis showed that, in all the analyzed TKO MEF
populations, more than 99.6% of the MEFs were Lrig3-negative
(Supplementary Table 1). Importantly, long-term culturing of the
TKO MEF lines for 60 days did not enrich for contaminating
wild-type MEFs as assessed with any of the three genotyping
methods (Supplementary Fig. 1; Supplementary Table 1). We
then compared wild-type and Lrig-null MEF lines with regard to
their proliferation and migration rates, morphology, and basic
metabolic functions. The proliferation rates were similar between
the wild-type and Lrig-null MEFs, both under standard cell cul-
ture conditions in 10% fetal bovine serum (FBS) (Supplementary
Fig. 1c) and under proliferation-limiting FBS concentrations,
although the Lrig-null MEFs showed a higher apparent pro-
liferation rate than the wild-type MEFs specifically with 5% FBS
(Supplementary Fig. 1d). The migratory rates of wild-type and
Lrig-null MEFs were also similar, in both 10% FBS and in 0% FBS
(Supplementary Fig. 1e). We were also unable to detect any
apparent difference in cell morphology between the wild-type and
Lrig-null MEF lines by light microscopy. Accordingly, flow
cytometry analysis did not reveal any significant differences in
forward or side scatter profiles between the wild-type and Lrig-
null MEF lines (Supplementary Table 2). We then analyzed basic
metabolic functions on a Seahorse XF analysis platform. These
analyses did not reveal any significant difference between the
wild-type and Lrig-null MEF lines with regard to their aerobic or
anaerobic responses, as measured by the oxygen consumption
rate (OCR) and extracellular acidification rate (ECAR), respec-
tively (Supplementary Fig. 1f, g).
Lrig proteins promote adipogenesis in vitro. To investigate the
role of Lrig proteins in adipogenesis in vitro, wild-type and Lrig-
null MEF lines were treated with an adipogenic cocktail con-
sisting of the glucocorticoid dexamethasone, the cAMP diesterase
inhibitor 3-isobutyl-1-methylxanthine, insulin, and the PPARγ
activator rosiglitazone. After nine days of treatment, adipocytic
transformation was assessed by Oil Red O staining. Three out of
four wild-type MEF lines were clearly able to transform into
adipocytes in response to the adipogenic cocktail, whereas all the
Lrig-null MEF lines studied showed impaired adipogenesis.
However, because the adipogenic potential was highly variable
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among the wild-type MEF lines, we included four additional
biological replicates of both wild-type and Lrig-null lines in the
analysis. Taken together, the analysis of the eight wild-type and
eight Lrig-null MEF lines clearly showed that compared to wild-
type MEFs, Lrig-null MEFs had deficient adipocyte differentiation
(Fig. 1a–c). During the adipogenic process of wild-type MEFs,
Lrig1 was downregulated and Lrig2 transiently upregulated,
whereas Lrig3 did not show any significant changes (Fig. 1d–f,
Supplementary Fig. 2a–f). It has been reported that the induction
of adipogenesis results in the rapid induction of Cebpb expres-
sion, followed by the induction of Pparg expression, and finally, in
differentiated adipocytes, Ap2 expression37–40. Gene expression
analyses via quantitative reverse transcription-PCR (qRT-PCR)
revealed that the induction of Cebpb was not diminished in Lrig-
null MEFs compared to in wild-type MEFs (Fig. 1g). However,
the induction of Pparg and Ap2 was severely impaired in Lrig-null
MEFs compared to in wild-type MEFs (Fig. 1h, i). Although Oil
Red O staining is a well-established method to visualize
triglyceride-containing adipocytes, we wanted to investigate the
biochemical changes in lipid composition that were associated
with adipogenesis in our experimental system. To this end, we
performed lipid profiling of the MEFs by liquid chromatography
coupled with tandem mass spectrometry prior to the adipogenic
treatment as well as eight days after the induction of adipogenesis.
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In total, 244 putative lipids were quantified. A principal compo-
nent analysis (PCA) of all samples did not reveal any apparent
difference between the wild-type and Lrig-null MEFs prior to
adipogenesis induction (Fig. 1j). Eight days after induction of
adipogenesis, both the wild-type and the Lrig-null MEF lines
separated distinctly from the untreated control MEFs. At this
time point, separation was also evident between wild-type and
Lrig-null MEFs. Thus, all the MEF lines responded to the adi-
pogenic stimulus by altering their lipid composition; however, the
wild-type and Lrig-null MEFs did so in different ways. In fact, a
supervised orthogonal projections to latent structures dis-
criminant analysis (OPLS-DA) plot completely separated the
treated wild-type samples from the treated Lrig-null samples
(Fig. 1k). The corresponding loadings plot, using the lipid classes,
showed that the main contributors to the separation between the
treated wild-type and treated Lrig-null samples were the tria-
cylglycerides, of which the majority showed higher levels in wild-
type MEFs than in Lrig-null MEFs (Fig. 1l).
TGF-β and BMP signaling pathways have been reported to
play important roles in adipogenesis in vitro and in vivo41.
Accordingly, the BMP inhibitor noggin was able to inhibit the
adipogenesis cocktail-induced adipogenesis of wild-type MEFs
(Fig. 1m). Conversely, a high dose of BMP4 (50 ng/ml) was able
to greatly enhance the cocktail-induced adipogenesis rate of wild-
type MEFs and, intriguingly, rescued the adipogenesis deficiency
of the Lrig-null MEFs (Fig. 1n).
Lrig-null MEFs show impaired BMP signaling. To investigate
the role of the LRIG proteins in BMP signaling, we used a BMP-
responsive element-driven luciferase reporter gene assay and
analyzed the phosphorylation levels of Smad1/5 by fluorescent
immunocytochemistry and Western blotting. First, we transiently
transfected the wild-type and Lrig-null MEFs with the BMP
reporter pGL3-BRE-luciferase and then stimulated them with
different concentrations of BMP4. In this assay, the Lrig-null
MEF lines showed a lower sensitivity to BMP4 than the wild-type
MEF lines (Fig. 2a). Similarly, the pSmad1/5 analysis showed that
the Lrig-null MEFs had a lower BMP4 sensitivity than the wild-
type MEFs (Fig. 2b); however, the maximal pSmad1/5 response
did not appear to differ between the wild-type and Lrig-null
MEFs in this assay. Additionally, the Lrig-null MEFs showed a
reduced sensitivity for BMP6 (Fig. 2c), whereas the sensitivity for
BMP9/GDF2 was similar between the wild-type and the Lrig-null
MEF lines (Fig. 2d). Compared with wild-type MEFs, Lrig1 and
Lrig3 single-knockout MEF lines (Supplementary Fig. 2g, h)
showed an apparently unaltered BMP4 sensitivity (Fig. 2e, f).
BMPs are also able to activate noncanonical BMP signaling,
which includes the activation of MAPK signaling cascades21,22.
Intriguingly, the Lrig-null MEFs showed a reduced sensitivity for
BMP4 when noncanonical phosphorylation of p38 was analyzed
(Fig. 2g–i); however, the detection of increased p38 phosphor-
ylation levels required higher BMP4 concentrations than the
detection of increased pSmad1/5.
To investigate whether the BMP signaling deficiency of the
Lrig-null MEF lines was the result of reduced expression of one or
several of the BMP receptors, the BMP receptor levels were
analyzed at the transcript level by RNA sequencing (RNAseq) and
at the protein level by Western blotting. The RNAseq analysis
revealed no significant difference in the levels of the different
BMP receptor transcripts between the wild-type and Lrig-null
MEF lines (Fig. 2j). Accordingly, Acvr1 and Bmpr2 showed
similar protein expression levels in wild-type and Lrig-null MEFs
when analyzed through Western blotting (Supplementary
Fig. 4a–c). In addition, there were no significant differences in
the transcript levels of Bmp ligands, signaling mediators,
responsive genes, or Tgf-β receptors (Fig. 2j).
LRIG1 and LRIG3 rescue BMP signaling in Lrig-null MEFs. To
investigate whether individual LRIG alleles could rescue the Lrig-
null phenotype, an Lrig-null MEF line was transduced with the
inducible human alleles LRIG1, LRIG2, or LRIG3, with an empty
vector serving as a control (Supplementary Fig. 2i–k). As assessed
by flow cytometry, a majority of the transduced cells expressed
LRIG1 or LRIG3 after induction, whereas the lower expression
level of LRIG2 made it difficult to determine the fraction of
LRIG2-positive cells with this method (Supplementary Fig. 2l–o).
Intriguingly, the induction of LRIG1 or LRIG3 expression rescued
the canonical BMP sensitivity phenotype of the Lrig-null MEFs,
whereas the induction of LRIG2 expression, or vector control, did
not (Fig. 3a–d). Interestingly, noncanonical BMP signaling
through p38 and Jnk phosphorylation was only rescued by LRIG1
and not by LRIG3 (Fig. 3e, f, g–j). Increased phosphorylation of
Erk was not observed under the BMP stimulation-protocol used
(Fig. 3e, f, k, l). To investigate whether LRIG1 and LRIG3 could
also rescue the adipogenesis deficiency of Lrig-null MEFs, LRIG1-
and LRIG3-inducible MEFs were analyzed. Clearly, the induced
Fig. 1 Lrig proteins regulate adipogenesis of MEFs in vitro. Wild-type (WT) and Lrig-null (TKO) MEFs were treated with an adipogenic cocktail as
described in the Methods section for the indicated times. a–c Adipogenesis of wild-type and Lrig-null MEF lines. Wild-type and Lrig-null MEFs were treated
with the adipogenic cocktail for nine days followed by the quantification of adipocytes via Oil Red O staining. Shown are representative images of wild-type
cells with 6% covered area (a) and Lrig-null cells with 1.7% covered area (b) (scale bar, 0.6 mm) and the quantifications of percentage area coverage for
the Oil Red O stained biological replicates (n= 8 per genotype) (c). d–i Relative mRNA expression levels of Lrig1 (d), Lrig2 (e), Lrig3 (f), Cebpb (g), Pparg
(h), and Ap2 (i). Cells were treated as in a-c. At the indicated time points after induction, the cells were lysed and analyzed by quantitative RT-PCR.
Expression was normalized to the reference gene Rn18s. Shown in d-f are wild-type cells only, whereas both wild-type and Lrig-null cells are shown in g–i, as
indicated, for eight biological replicates per genotype. j–l Lipidomic analyses. Lipids were extracted from wild-type and Lrig-null MEFs before or after eight
days of treatment with the adipogenic cocktail. Lipid analysis was then performed by liquid chromatography coupled with tandem mass spectrometry. Each
symbol represents one experimental replicate; shown are the results of three biological replicates per genotype with four experimental replicates each.
j PCA score plots of all samples, labeled according to sample category. The variation explained by PC1 and PC2 was 39.6% and 33.6%, respectively. k The
score plot of the OPLS-DA model built from the lipid profiles of the 8-day samples to determine the maximal variance between the wild-type and Lrig-null
sample groups. l The corresponding loading plot explaining the contributions of different lipid species to the OPLS-DA model, indicating that triglycerides
(TGs) (red triangles) in the wild-type samples were highly enriched compared to in the Lrig-null samples. The lipids are labeled according to lipid class (DG:
diacylglycerol, PC: phosphatidylcholine, PE: phosphatidylethanolamine, PS: phosphatidylserine, SM: sphingomyelin, TG: triacylglycerol). m, n Role of BMP
for adipogenesis in vitro. Wild-type and Lrig-null MEFs were treated as in a, without (Ctrl) or with the addition of 100 ng/ml of the BMP inhibitor noggin
(Noggin) (m), or without (Ctrl) or with the addition of 50 ng/ml of BMP4 (BMP4) (n). Adipogenesis was scored through Oil Red O staining as described
under a. In c–i, m and n the means of the biological replicates (c, g–i, m and n, n= 8 per genotype; d–f, n= 3) are shown by horizontal lines, and the means
of the individual biological replicates analyzed by three experimental repeats are shown by dots and squares. Error bars represent the standard deviations
of the means of the biological replicates. nsP > 0.05, *P < 0.05, **P < 0.01 (Student’s t-test).
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Fig. 2 Lrig-null MEFs show impaired BMP signaling without any apparent changes in the expression of receptors or signaling mediators. a Wild-type
(WT) and Lrig-null (TKO) MEFs expressing the BMP reporter plasmid pGL3-BRE-luciferase were treated with the indicated concentrations of BMP4 for three
hours. Thereafter, the cells were lysed, and the luciferase activity was analyzed and normalized to the control. b–d Wild-type and Lrig-null MEFs were
stimulated with various concentrations of BMP4 (b), BMP6 (c), or BMP9 (d) for one hour followed by immunocytofluorescence analysis of nuclear
phospho-Smad1/5 (pSmad1/5). e, f Wild-type and Lrig1-null MEFs (e) or wild-type and Lrig3-null MEFs (f) were stimulated with various concentrations of
BMP4 for one hour followed by nuclear pSmad1/5 analysis. g–i Western blot analyses of canonical BMP4 signaling through pSmad1/5 and noncanonical
BMP signaling through phosphorylated p38 (pp38). Wild-type and Lrig-null MEFs were stimulated with the indicated concentrations of BMP4 for one hour
followed by cell lysis and Western blot analysis. Uncropped blots are shown in Supplementary Fig. 3. g Representative Western blots showing pSmad1/5,
pp38, total Smad1, total p38, and the loading control actin. h Quantification of the pSmad1/5/actin ratios. i Quantification of the pp38/actin ratios. j Gene
expression levels were analyzed in wild-type (WT) and Lrig-null (TKO) MEFs via RNA sequencing (RNAseq). The apparent number of RNAseq reads for
respective gene is indicated. All the values in a–f, h and i represent the means of four biological replicates that were analyzed by three experimental repeats
each. j The values represent the means of four biological replicates that were analyzed once. Error bars represent the standard deviations of means from
four biological replicates. nsP > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test).
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expression of LRIG1 or LRIG3 enhanced the adipogenesis rate of
the MEF lines (Fig. 3m). To investigate whether the observed
sensitizing effects of LRIG proteins on BMP signaling were
restricted to MEFs, or if it was a more general phenomenon, the
LRIG1-inducible human HEK293T and A375 cell lines were
analyzed. Clearly, when LRIG1 expression was induced in
HEK293T or A375 cells, both cell lines showed a greatly
enhanced sensitivity to low concentrations of BMP4 (Fig. 3n, o).
To compare the BMP4-sensitizing potencies of the human LRIG
proteins, different levels of LRIG1, LRIG2, or LRIG3 were
induced by titrating the specific transcription-inducer doxycy-
cline. Then, the correlations between the LRIG protein expression
levels and the BMP4-induced pSmad1/5 levels were determined.
This correlation analysis revealed that LRIG1 and LRIG3 were
approximately equally potent in sensitizing the Lrig-null MEFs to
BMP4; as expected, LRIG2 showed a negligible effect on
BMP4 signaling (Fig. 4a). Next, we performed a structure-
function analysis of the relationships between different protein
domains and the BMP-sensitizing function of LRIG1. To this end,
Lrig-null MEFs were transiently transfected with different
amounts of expression vectors encoding a green fluorescent
protein (GFP) -tagged full-length LRIG1, a GFP-tagged LRIG1
variant that lacked the cytosolic tail (LRIG1-Δcyto), or GFP only
(as transfection control). Because of the poor transfection
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efficiencies of our MEF lines, the background signals from the
majority of nontransformed Lrig-null cells imposed an analytical
problem. To resolve this problem, we changed the stimulation
protocol from 2.5 ng/ml BMP4 for 60 min to 20 ng/ml BMP4 for
20 min. This modified protocol enabled us to monitor the
pSmad1/5 signals among the minority of LRIG1-transformed
MEFs while keeping the background signals from the majority of
nontransformed Lrig-null MEFs to a minimum. By correlating
the BMP4-induced pSmad1/5 responses with the expression
levels of the transfected LRIG1 or LRIG1-Δcyto proteins, it was
revealed that full-length LRIG1 and LRIG1-Δcyto were approxi-
mately equally potent in promoting BMP4 signaling in the Lrig-
null MEFs (Fig. 4b). The BMP4-sensitizing function of full-length
LRIG1 was also compared with the isolated ectodomain of
LRIG1, that is, LRIG1 lacking its transmembrane and cytosolic
domains. Apparently, the LRIG1 variant lacking the transmem-
brane and cytosolic domains lost its BMP4-sensitizing function
(Fig. 4c). Thus, the cytosolic tail, but not the transmembrane
domain, was dispensable for the BMP-sensitizing function of
LRIG1 in the context studied.
TGF-β and RTK-MAPK signaling pathways appear to be Lrig-
independent in MEFs. Because the TGF-β and BMP signaling
pathways share many common features and because RTK sig-
naling has been reported to be regulated by LRIG proteins, we
Fig. 3 Ectopic LRIG1 or LRIG3 resensitize Lrig-null cells to BMP4. a–m Lrig-null MEFs were transduced with doxycycline-inducible LRIG1, LRIG2, or LRIG3
constructs or with empty vector as a noninducible control. LRIG protein expression was not induced or induced by treatment of the cells with 100 ng/ml
(a–d, m–o) or 500 ng/ml (e–l) doxycycline for 24 h followed by stimulation of the cells with different concentrations of BMP4 for one hour (a–l, n, o) or
with adipogenic cocktail for ten days (m). a–d Immunofluorescence analyses of nuclear pSmad1/5 in cells not induced (−dox) or induced (+dox) to
express LRIG1 (a), LRIG2 (b), or LRIG3 (c). The empty vector served as a negative control for doxycycline treatment (d). e–l Western blot analyses of
canonical (pSmad1/5) and noncanonical (pp38, pJnk, and pErk) BMP4 signaling. LRIG1- or LRIG3-inducible MEFs were induced, or not induced, with
doxycycline followed by stimulation with 0 or 20 ng/ml of BMP4 for one hour. Thereafter, the cells were lysed, and the lysates were analyzed by Western
blotting. e, f Representative Western blots showing pSmad1/5, total Smad1, pp38, total p38, pJnk, total Jnk, pErk, total Erk, LRIG1-FLAG (e), LRIG3-FLAG
(f), and the loading control actin. Uncropped blots are shown in Supplementary Fig. 5. g–l Quantification of pp38 (g, h), pJnk (I, j), and pErk (k, l)
normalized to actin in LRIG1-inducible (g, I, k) or LRIG3-inducible (h, j, l) MEFs. Plotted values in a–d represent means from three biological replicates, each
with three experimental repeats. Error bars represent the standard deviations of means from three biological replicates. g, h Shown are four experimental
repeats using an LRIG1- or LRIG3-inducible MEF line. Error bars show the standard deviations of the four means. i–l Shown are three experimental repeats
using an LRIG1- or LRIG3-inducible MEF line. Error bars show standard deviations of the four means.m LRIG1 or LRIG3 expression was induced or not in Lrig-
null MEFs with doxycycline followed by treatment of the cells with the adipogenic cocktail for ten days and quantification of adipocytes via Oil Red O
staining. Shown are quantifications of the percentage area coverage for the Oil Red O stained biological replicates (n= 3 per genotype and treatment).
n, o LRIG1 expression was induced or not in LRIG1-inducible HEK293T cells (n) and A375 cells (o) via the treatment of cells with doxycycline for 24 h,
followed by stimulation with different concentrations of BMP4 for one hour. Immunofluorescence analyses of nuclear pSmad1/5 in HEK293T cells (n) or
A375 cells (o) that were not induced (-dox) or induced (+dox) to express LRIG1, with empty vector serving as a noninducible control. Plotted values in
n and o represent the means from three independent experiments, performed as triplicates using one biological replicate of each cell line. Error bars
represent standard deviations from three means. nsP > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test).
a c
0 100 200 300 400 500
0
50
100
150
200
Flag antibody fluorescence
pS
m
ad
1/
5 
flu
or
es
ce
nc
e LRIG1-Flag
LRIG1-Ecto-Flag
b
LRIG1-GFP
LRIG1- cyto-GFP
GFP
0 500 1000 1500
0
200
400
600
800
1000
Flag antibody fluorescence
pS
m
ad
1/
5 
flu
or
es
ce
nc
e
LRIG1-Flag
LRIG2-Flag
LRIG3-Flag
Empty vector
0 500 1000 1500
0
100
200
300
400
500
GFP fluorescence
pS
m
ad
1/
5 
flu
or
es
ce
nc
e
Fig. 4 LRIG1 and LRIG3 promote BMP signaling. a Different LRIG protein expression levels were induced in LRIG-inducible MEFs by treating the cells with
different concentrations of the inducer doxycycline. Thereafter, the cells were stimulated with 2.5 ng/ml BMP4 for one hour followed by
coimmunocytofluorescence analyses of nuclear pSmad1/5 and the FLAG-epitope present as a tag on the induced LRIG proteins. Correlation plots of
phosphorylated Smad1/5 versus the FLAG-LRIG protein expression levels are shown. Fitted lines indicate the linear relationship with pSmad1/5 for each
LRIG protein. Pearson’s correlation coefficients for the respective genes were LRIG1, 0.9162; LRIG2, 0.6939; LRIG3, 0.9251; and empty vector, 0.1659.
Shown are three experimental repeats using three biological replicates. b Lrig-null MEFs were transfected with a full-length LRIG1-GFP fusion protein
(LRIG1-GFP), an LRIG1-GFP fusion protein variant lacking the cytosolic domain of LRIG1 (LRIG1-Δcyto-GFP), or empty vector (GFP) as a transfection
control. Thereafter, the cells were stimulated with 20 ng/ml of BMP4 for 20min followed by coimmunocytofluorescence analyses of nuclear pSmad1/5
and the green fluorescence from GFP fusion proteins or control GFP. The correlation plots between pSmad1/5 and GFP fluorescence are shown. The fitted
lines indicate the linear relationship to pSmad1/5 for the respective construct. Pearson’s correlation coefficients for the respective constructs were as
follows: full length LRIG1, 0.8943; LRIG1-Δcyto, 0.9663; GFP control, 0.2564. Shown are two experimental repeats using three biological replicates. c Lrig-
null MEFs were transfected with different amounts of expression vectors encoding FLAG-tagged full-length LRIG1 (LRIG1) or FLAG-tagged LRIG1
ectodomains (LRIG1-ecto). Thereafter, the cells were stimulated with 20 ng/ml of BMP4 for 20min followed by coimmunocytofluorescence analyses of
nuclear pSmad1/5 and the FLAG-epitope. Shown are the correlation plots between pSmad1/5 and FLAG-LRIG expression levels. Fitted lines indicate the
linear relationship between pSmad1/5 and the respective FLAG-LRIG construct. Pearson’s correlation coefficients for the respective constructs were as
follows: full-length LRIG1, 0.7393; and LRIG1-ecto, 0.5287. Shown are two experimental repeats using three biological replicates.
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also compared TGF-β and RTK signaling between wild-type and
Lrig-null MEFs. TGF-β signaling was assessed using a TGF-β-
responsive element-driven luciferase reporter, p(CAGA)12MLP-
Luc, assay42 or by analyzing the phosphorylation levels of Smad3
by fluorescent immunocytochemistry. Neither of these analyses
revealed any significant difference between wild-type and Lrig-
null MEFs with regard to their TGF-β1 responses (Fig. 5a, b). To
investigate the role of Lrig proteins in steady-state RTK signaling
levels in MEFs under standard cell culture conditions with 10%
FBS, a phospho-RTK array was used. Surprisingly, there was no
apparent difference in the specific RTK phosphorylation levels
between the wild-type and Lrig-null MEFs under the standard cell
culture conditions employed (Fig. 5c). To further analyze the role
of LRIG proteins in RTK signaling, a wild-type MEF line carrying
floxed Lrig alleles was stably transduced with the MAPK reporter
gene ELK1/SRF-luc. Thereafter, the stably transduced MAPK
reporter MEFs were transduced with Cre recombinase or a
control vector to generate four independent MAPK reporter Lrig-
null MEF lines together with four MAPK reporter wild-type MEF
lines (Supplementary Fig. 4d–f). When these MEF lines were
treated with different concentrations of platelet-derived growth
factor (PDGF) -BB, luciferase expression was induced; however,
there was no apparent difference in the sensitivity to PDGF-BB
between the wild-type and Lrig-null MEFs (Fig. 5d). Additionally,
the dose-response of PDGF-BB-induced proliferation was similar
between the wild-type and Lrig-null MEF lines (Fig. 5e).
The LRIG homolog sma-10 regulates lipid metabolism in C.
elegans. In C. elegans, LRIG/SMA-10 is reported to promote
normal body size through BMP signaling12. Given that several
BMP mutants have been reported to be defective in lipid
homeostasis34,35, we hypothesized that defective lipid home-
ostasis could be a general trait of BMP mutants, including
0.5 1.0 1.5 2.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
TGF- 1 concentration [ng/ml]
R
el
at
iv
e 
lu
m
in
es
ce
nc
e WT
TKO
a b
c
d e
5 10 15 20 25
-0.2
0.0
0.2
0.4
0.6
PDGF-BB concentration [ng/ml]
O
D
 [5
70
]
WT
TKO
0.0 0.5 1.0 1.5
0
500
1000
1500
2000
2500
TGF- 1 [ng/ml]
pS
m
ad
3 
flu
or
es
ce
nc
e
WT
TKO
0 5 10 15
0
10000
20000
30000
PDGF-BB concentration [ng/ml]
R
el
at
iv
e 
lu
m
in
es
ce
nc
e WT
TKO
Eg
fr
Er
bb
2
Er
bb
3
Er
bb
4
Fg
fr2
Fg
fr3
Fg
fr4Ins
r
Igf
1r Ax
l
Dt
k
Me
r
Hg
fr
Ms
pr
Pd
gfr
a
Pd
gfr
b
Sc
fr
Flt
3
Mc
sfr Re
t
Tie
1
Tie
2
Trk
a
Trk
b
Trk
c
Ve
gfr
1
Ve
gfr
2
Ve
gfr
3
Mu
sk
Ep
ha
1
Ep
ha
2
Ep
ha
3
Ep
ha
6
Ep
ha
7
Ep
ha
8
Ep
hb
1
Ep
hb
2
Ep
hb
4
Ep
hb
6
1 102
1 103
1 104
1 105
1 106
R
ec
ep
to
r p
ho
sp
ho
ry
la
tio
n
WT
TKO
Fig. 5 TGF-β and RTK signaling appear unaltered in Lrig-null MEFs. a Wild-type (WT) and Lrig-null (TKO) MEFs were stimulated with various
concentrations of TGF-β1 for one hour and then analyzed for nuclear phospho-Smad3 (pSmad3) by an immunocytofluorescence assay. b Wild-type and
Lrig-null MEFs were transiently transfected with the TGF-β reporter plasmid p(CAGA)12MLP-Luc followed by treatment of the cells with the indicated
concentrations of TGF-β1 for three hours. Cell lysates were then analyzed for luciferase activity. Shown is the relative luminescence on an arbitrary scale.
cWild-type and Lrig-null MEFs, cultivated under standard cell culture conditions in 10% FBS, were lysed and analyzed for RTK phosphorylation levels with a
phospho-RTK array kit (R&D Systems). dWild-type and Lrig-null MEFs stably expressing the MAPK reporter gene ELK1/SRF-luc were treated with different
concentrations of PDGF-BB for four hours and then lysed and analyzed for luciferase activity. e Wild-type and Lrig-null MEFs were cultivated in FBS-free
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values of treated MEFs normalized to those of untreated MEFs. a, b, d and e The plotted values represent the means of four biological replicates, each with
three experimental repeats. c The plotted values represent the means of four biological replicates, each with one experimental repeat. Error bars represent
the standard deviations of the means from four biological replicates.
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mutants for LRIG/sma-10. As a BMP pathway-independent
control for short body length, we included the cuticle collagen
mutant dpy-5(e907) in our analysis43. Both body length and fat
accumulation were assessed in wild-type and mutant worms
(Fig. 6a–c). As expected, compared to wild-type worms, all of the
dpy-5, sma-10, daf-4, sma-6, and sma-3 mutant worms showed a
reduced body length (Fig. 6a, b). Intriguingly, compared to lipid
accumulation in wild-type worms, lipid accumulation was
reduced in both the LRIG/sma-10 mutants wk88 and wk89, in the
ACVR2A and ACVR2B homolog mutant daf-4(m63) and in the
SMAD1 homolog mutant sma-3(wk30) (Fig. 6a, c). Compared to
the wild-type, also the BMPR1A/sma-6(wk7) mutants showed an
apparent, although nonsignificant (p= 0.14), reduction in lipid
accumulation. For unknown reasons, the sma-6(wk7) series
showed a higher variance than the other BMP mutants, which
might have contributed to the lack of significance for this series.
Despite being short, the dpy-5(e907) mutants had normal levels of
lipid deposits in lipid-storing intestinal cells. Short body length
per se thereby appears uncoupled from fat accumulation in
somatic tissue of C. elegans. Hence, we conclude that LRIG/sma-
10 promotes lipid accumulation in postmitotic tissue of C. ele-
gans, likely through BMP signaling and independent of body size
regulation.
Human LRIG1 variants are associated with an altered risk of
type 2 diabetes and with BMI and adipocyte morphology. To
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Fig. 6 LRIG/sma-10 and other BMP pathway genes promote lipid accumulation in lipid-storing cells in C. elegans, and LRIG1 SNPs predict BMI and type
2 diabetes in humans. a Representative whole-body images of Oil Red O-stained adult hermaphrodite worms. Scale bars, 200 μm. b Adult body lengths of
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the right represents the odds ratios for T2D. In this study, the minor allele was associated with an increase in BMI and a lower odds of T2D risk.
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investigate possible associations between LRIG gene variants and
human metabolism and metabolic disease, data from the UK Bio-
bank were analyzed (n= 398,810, Supplementary Table 3 for par-
ticipant characteristics). Here, we identified nine variants at LRIG1
that were strongly associated with BMI (P < 5 ×10−8) (Supple-
mentary Table 4); these signals have also been reported by others as
a part of a larger meta-analysis conducted while this study was in
progress44. In our analyses, each copy of the minor allele of
rs4856886 (G) (tag SNP with the strongest effect) increased the
BMI by ~0.05 kg/m2 (Fig. 6d); this phenomenon was largely
attributed to genetic variation (Supplementary Table 5). These
variants were also associated with a decreased risk of diabetes and
adjusting for BMI strengthened these associations (Fig. 6d; Sup-
plementary Table 6). Secondary signals for many other metabolic
traits, including plasma triglyceride levels (Supplementary Table 7),
were also observed, suggesting a metabolically favorable phenotype
in people carrying the BMI-associated LRIG1 alleles. The results of
association with liver fat percentage were not significant (Supple-
mentary Table 8), which might be attributable to the low statistical
power given the relatively small sample size (n= 3,192, compared
to n= 398,810 for other analyses). We hypothesized that the
observed relationships may be attributed to a metabolically favor-
able adipose tissue phenotype, which is typically observed in
adipose tissue comprised of many small adipocytes, i.e., hyperplastic
adipose morphology45. Thus, for the two strongest LRIG1 signals
from UK Biobank (rs4856886 and rs9840088), we tested associa-
tions with adipocyte size in adults from the GENiAL cohort (n=
948, Supplementary Table 9). In these analyses, the BMI increasing
(type 2 diabetes risk decreasing) alleles at rs4856886 (P= 0.039)
and rs9840088 (P= 0.014) were associated with adipose hyperpla-
sia. For rs9840088, the mean adipose morphology values were +7.5
picolitres for the common A allele and −9.2 picolitres for the
minor C allele (P= 0.026 by analysis of covariance, adjusted
for age).
Discussion
Lipid metabolism is central to energy homeostasis at both the
cellular and organismal levels. Here, we found that the LRIG
proteins function as regulators of lipid metabolism by regulating
BMP signaling in several different biological systems, including
adipocyte differentiation of mouse fibroblasts and in lipid accu-
mulation in C. elegans; in addition, we found that human LRIG1
gene variants were associated with a decreased risk of type 2
diabetes, an increased BMI, and altered adipocyte morphology.
Collectively, these observations show that LRIG proteins function
as evolutionarily conserved regulators of BMP signaling and lipid
metabolism and have important implications for human meta-
bolic health.
LRIG proteins regulated lipid accumulation and adipogenesis
of MEFs in response to adipogenic stimuli. The former was
shown by a reduced triglyceride accumulation, whereas the latter
was suggested by a reduced number of equally sized Oil Red O-
positive cells and impaired induction of the adipocyte markers
Pparg and Ap2 among the Lrig-null MEFs. Furthermore, the
associations between LRIG1 gene variants and adipocyte numbers
in humans suggests that LRIG proteins might also regulate adi-
pogenesis in vivo in humans. However, although the lipid profiles
of undifferentiated MEFs were indistinguishable between the
wild-type and Lrig-null cells, our experiments did not address
whether LRIG proteins could regulate metabolism in differ-
entiated adipocytes. In this regard, it was intriguing that the
LRIG/sma-10 mutant nematodes also showed a lipid accumula-
tion defect, although C. elegans lack dedicated adipocytes. Thus,
further investigations will reveal whether mammalian LRIG
proteins, in addition to regulating adipogenesis, also regulate lipid
metabolism in differentiated energy-regulating cells such as adi-
pocytes, hepatocytes, or skeletal muscle cells.
The sole C. elegans LRIG homolog, SMA-10, regulates body
size by regulating BMP signaling. Here, we showed that the BMP-
promoting function of SMA-10 is conserved in human LRIG1
and LRIG3, which promoted BMP signaling by increasing sig-
naling strength at low BMP4 and BMP6 ligand concentrations.
These results show that the BMP signal-regulating function of the
hypothesized common protein ancestor of nematode SMA-10
and mammalian LRIG proteins seems to be retained in human
LRIG1 and LRIG3, but not in LRIG2. This finding is consistent
with a recent whole genome CRISPR-Cas9 phenotypic screen for
regulators of BMP signaling in HEK293 cells46. In this dataset,
LRIG1 and LRIG3 were among the 170 significant activators of
BMP2-induced signaling, whereas LRIG2 was not (https://orcs.
thebiogrid.org/Screen/172). Our demonstration that the human
LRIG1 cytosolic domain was dispensable for its BMP signal-
promoting function is consistent with the fact that in contrast to
the mammalian LRIG proteins, C. elegans SMA-10 lacks a pro-
minent cytosolic domain but still promotes BMP signaling.
Intriguingly, the mammalian LRIG proteins showed a striking
specificity with regard to the BMP pathways that they regulated.
Thus, BMP4 and BMP6 signaling was strongly dependent on
LRIG proteins, whereas BMP9 signaling was not. This dis-
crimination between the BMP4/6 and BMP9 pathways may
indicate possible molecular targets for the mammalian LRIG
proteins. BMP4, BMP6, and BMP9 share the same type 2
receptors; however, BMP4 and BMP6 specifically interact with
the type 1 receptors BMPR1A (ALK-3) and BMPR1B (ALK-6),
whereas BMP9 specifically interacts with ACTRL1 (ALK-1).
Accordingly, it can be speculated that LRIG1 and LRIG3 may
regulate the BMP type 1 receptors BMPR1A and/or BMPR1B but
not the type 2 receptors or the type 1 receptor ACTRL1. Mam-
malian LRIG proteins specifically regulating type 1 BMP recep-
tors would be in line with the demonstration that C. elegans
SMA-10 is required for the proper trafficking of SMA-6, a type 1
BMP receptor, but not for the trafficking of DAF-4, the type 2
receptor regulating body size13. Curiously, we found that LRIG1,
but not LRIG3, could rescue noncanonical BMP signaling
through p38 and Jnk MAPKs. The molecular basis for these
specific functions of LRIG proteins remains to be elucidated.
We further examined whether genetic variation in LRIG1 was
associated with risk of type 2 diabetes, BMI, and adipocyte
morphology among humans. Intriguingly, we identified diabetes-
preventing LRIG1 alleles that were strongly associated with an
increased BMI and hyperplastic adipose morphology, e.g. many
small adipocytes given total body fat. All the identified SNPs were
intronic, and their functional exploration in humans remains to
be undertaken. However, because we also found that LRIG1
enhanced both BMP signaling and adipogenesis, it seems rea-
sonable to speculate that the diabetes-preventing LRIG1 alleles
may stimulate adipogenesis by enhancing BMP signaling. The
diabetes-protecting effect could, thus, result from a more efficient
use of excess energy by the LRIG1-mediated increased number of
adipocytes47. Further analyses of the associations between LRIG1
gene variants and human metabolic traits may unravel further
insights about the physiological function of LRIG1. Nevertheless,
LRIG1, LRIG3, or other functionally associated proteins may
provide novel targets for the prevention or treatment of type 2
diabetes or other metabolic diseases. However, the molecular
mechanisms involved need to be elucidated before potential
clinical applications can be explored.
We propose that LRIG proteins play important roles as BMP
sensitizers in the context of lipid metabolism, during develop-
ment, in tissue homeostasis, and in diseases such as cancer. In this
regard, it is intriguing that Lrig3-deficient mice show both
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craniofacial and inner ear defects48, which are consistent with the
central role for balanced BMP signaling during the development
of these anatomical structures49,50. Similarly, we suggest revisiting
the Lrig1-deficient phenotypes, including the cutaneous51,52 and
intestinal9,53 cell hyperproliferation phenotypes, to investigate the
role of dysregulated BMP signaling in these processes. In cancer,
the roles of LRIG1 and LRIG3 should be re-evaluated in light of
their functions as BMP sensitizers. In glioma, for example, LRIG1
functions as a tumor suppressor11, as does BMP signaling54–56.
Thus, it can be hypothesized that LRIG1 may suppress glioma
growth by enhancing BMP signaling, in addition to its previously
proposed regulation of RTK signaling.
Future in vitro cell culture experiments concerning LRIG pro-
teins need to take into consideration the BMP content in FBS.
Commercial FBS, which is commonly used for in vitro cell cul-
tivation, contains BMP ligands in concentrations ranging from 6
to 14 ng/ml57,58, i.e., concentrations where the sensitizing func-
tions of LRIG1 and LRIG3 were highly relevant. Thus, endogen-
ously expressed LRIG proteins are likely to affect BMP signal
transduction in cells cultured under standard conditions with FBS.
Lrig-null mice are not viable2. Nevertheless, the only clear
phenotype that we could establish for the Lrig-null MEFs was
impaired adipogenesis and a reduced sensitivity for BMP4 and
BMP6. The Lrig-null MEFs did not show any obvious phenotype
regarding their viability, morphology, proliferation, migration,
energy metabolism, or signaling through TGF-β or RTKs. The lack
of a detectable RTK phenotype was particularly intriguing given
the substantial body of evidence showing that LRIG proteins reg-
ulate RTK signaling. Thus, compared to the wild-type MEFs, the
Lrig-null MEFs showed no apparent alterations in their steady-
state levels of phosphorylated RTKs, PDGF-driven cell prolifera-
tion, or PDGF-induced reporter gene activation. The reason for the
apparent lack of an RTK phenotype in the Lrig-null cells remains
enigmatic. Hypothetically, one possible explanation could be a
canceling-out effect that occurs when knocking out of genes with
opposing functions. For example, LRIG1 and LRIG3 have been
shown to have opposing functions with regard to the regulation of
ERBB RTKs59. It is also possible that the RTK-regulating functions
of LRIG proteins become apparent only under specific conditions,
such as those observed when signaling proteins are ectopically
overexpressed, as has been the case in many of the previous
studiese.g.,5,6,7,8,10,11. It may also be relevant to consider possible
cross-talk between the BMP and RTK signaling pathways, i.e., a
primary effect on one of the pathways may indirectly affect the
other pathway and vice versa. In this regard, the timing of the
different events will be important to resolve to shed light on their
causal relationships. Nevertheless, the Lrig-null MEFs revealed that
the LRIG proteins are not required for basal RTK signaling, at least
not in MEFs under standard cell culture conditions.
In summary, we showed that mammalian LRIG proteins
function as cellular BMP sensitizers and regulators of adipogen-
esis. Furthermore, we showed that the C. elegans LRIG homolog,
sma-10, also regulates lipid accumulation in the worm. Impor-
tantly, specific human LRIG1 gene variants were associated with a
decreased risk of type 2 diabetes, increased BMI, and altered
adipocyte morphology, suggesting that LRIG proteins play
important physiological roles in the regulation of lipid home-
ostasis in humans. It will be important to further investigate the
detailed molecular mechanisms involved, which could unravel
new molecular players and treatment targets for common human
metabolic diseases.
Methods
Cell lines and cell culture. MEFs were isolated from 12-day-old mouse embryos
with floxed Lrig genes (Lrig1flox/flox;Lrig2flox/flox;Lrig3flox/flox) that had been gener-
ated through interbreeding of the previously described mouse strains B6.129-
Lrig1tm1Hhed 11, B6.129-Lrig2tm1Hhed60, and B6.129-Lrig3tm1Hhed36 or from
embryos with wild-type or deficient Lrig1 or Lrig3 genes that had been obtained
from inter crosses of B6.129-Lrig1tm1.1Hhed11 or B6.129-Lrig3tm1.1Hhed mice36,
respectively, in a C57BL/6 J genetic background. All mice were housed and
maintained and all experiments performed in accordance with the European
Communities Council Directive (86/609/EEC). Experimental protocols were
approved by the Regional Ethics Committee of Umeå University, Umeå, Sweden
(registration nos. A5-2010, A193-12, and A1-16). The cells were immortalized
according to the 3T3 protocol described by Todaro and Green61. The MEFs were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich Sweden
AB, Stockholm, Sweden) supplemented with 10% FBS (Fisher Scientific GTF AB,
Gothenburg, Sweden), MEM-nonessential amino acids (Fisher Scientific GTF AB),
50 μM 2-mercaptoethanol (Sigma-Aldrich Sweden AB), and 50 μg/ml gentamicin
(Invitrogen, Fisher Scientific GTF AB). In experiments where MEFs were subjected
to multiple washes, the cell culture plates were coated with 0.1% bovine gelatin
(Sigma-Aldrich Sweden AB, catalog # G9391) for 30 min at 37 °C prior to cell
seeding. To generate Lrig-null (Lrig1-/-;Lrig2-/-;Lrig3-/-) cells, herein also referred to
as TKO cells, the triple-floxed cells were transduced with adenovirus Ad(RGD)-
GFP-iCre or its control adenovirus Ad(RGD)-GFP (Vector Biolabs, Malvern, PA,
USA) at a multiplicity of infection of 100 and a cell seeding density of 10,300 cells/
cm2. Twenty-four hours after adenovirus transduction, the cells were washed with
phosphate-buffered saline (PBS), and after an additional 24 h, the top 20% of cells
that showed the highest green fluorescence intensity were isolated using a FAC-
SAria III cell sorter (BD Biosciences, San Jose, CA, USA). The transduction-
selection procedure was repeated independently four times, thereby producing four
different cell line pairs composed of an Lrig-null and a wild-type MEF line named
TKO1-4 and WT1-4, respectively. LRIG-inducible MEF lines were generated by
stably transducing an Lrig-null MEF line with a doxycycline-inducible LRIG1,
LRIG2, LRIG3, or empty control vector according to a previously described pro-
tocol11. The LRIG1-inducible human embryonic kidney cell line HEK293T, clone
32:3:10, has been described previously62, and the human melanoma cell line A375
was obtained from Dr. Oskar Hemmingsson of Umeå University. A375 cells were
profiled for short tandem repeats (STRs) by American Type Culture Collection
(ATCC) and were confirmed to have a 100% match with the ATCC cell line CRL-
1619 (A375). HEK293T cells and A375 cells were cultured in DMEM supple-
mented with 10% FBS and 50 μg/ml gentamicin. The cell culture plates used for
HEK293T and A375 cells were coated with 10 μg/ml poly-D-lysine (Sigma-Aldrich
Sweden AB, catalog # P0899) for 30 min at 37 °C followed by washes with PBS
before the cells were plated. The LRIG1-deficient A375 subclone, clone Pc1-5-4,
was generated via CRISPR-Cas9-mediated mutagenesis. To this end, two sgRNAs
targeting both strands of LRIG1 exon 11, were cloned into the pD1401-AD plasmid
(Atum, Newark, CA, USA), which contains a Cas9(D10A)-GFP-nickase sequence
under the CMV promoter. A375 cells were transfected with the resulting plasmid
using Lipofectamine 2000 (Fisher Scientific GTF AB) according to the manu-
facturers protocol. GFP-positive cells were then single-sorted into 96-well plates
containing DMEM supplemented with 10% FBS and 200 U/ml penicillin-
streptomycin (Fisher Scientific GTF AB) using a BD FACSAria™ III sorter. Single
cells were expanded, split, and expanded as duplicates in 6-well plates. One well in
each duplicate was lysed and screened for large indels and insertions using PCR
(forward primer sequence: 5′-CATTCCATGGGCTTGTGTTG-3′, reverse primer
sequence: 5′-CCACTACCATTAATCAGAC-3′). Genomic DNA from a clone that
lacked the 278-bp wild-type band was then PCR amplified using primers flanking
LRIG1 exon 11 (forward primer sequence: 5′-GTTTGACTCTAACTCTGTTG-3′,
reverse primer sequence: 5′-GCATAATGCAATTGCAGAAG-3′). Each of the
three resulting bands were purified and cloned into a TOPO vector (Fisher Sci-
entific GTF AB), sequenced, and found to represent three different mutant variants
of LRIG1: one with a deletion and one with an insertion, both resulting in fra-
meshifts; the third had a silent intronic insertion, and both PAM sequences were
intact. By repeating the entire mutational process on this clone, we isolated the
Pc1-5-4 subclone, which was found to contain an additional insertion close to the
splice acceptor site at the intron 10/exon 11 boundary. The LRIG1-inducible A375
cell line was generated through the cotransduction of the A375 clone Pc1-5-4 with
the vectors pLVX-LRIG1-TRE3G and pLVX-Tet3G as described previously for
other cells11. Lentiviral particles with vectors for the srf/elk-1 luciferase reporter and
Renilla control were obtained from Qiagen AB (Sollentuna, Sweden, catalog nos.
CLS-010L and CLS-RCL, respectively) and were used to cotransduce triple-floxed
MEFs with 10 infection units (IU) per cell for srf/elk-1 and 3.2 IU per cell for
Renilla. Stably transduced MEFs were selected with puromycin. Thereafter, Lrig-
null (TKO) and control (WT) MEF lines were generated independently four times
from the puromycin-resistant MEFs through transduction of the cells with Ad
(RGD)-GFP-iCre or Ad(RGD)-GFP as described above.
PCR and ddPCR genotype analyses. The mouse Lrig genotypes were routinely
monitored via allele-specific PCRs using primers 5′-CATCGCATTGTCTGAG
TAGGTGTC-3′ and 5′-CTCCAGAATCACGCTCACCT-3′, yielding an 824 bp
product for the floxed wild-type Lrig1 allele and no product for the knockout allele,
primers 5′-TGCACTAGGCAGTCTTAAACCA-3′ and 5′-TCAGGCAGTGACA
GAAGGTGT-3′, yielding a 450 bp product for the floxed wild-type Lrig2 allele and
no product for the knockout allele, and primers 5′-CATCGCATTGTCTGAG
TAGGTGT-3′ and 5′-CGAGGCTGATGGTCTGCTAAT-3′, yielding a 630 bp
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product for the floxed wild-type Lrig3 allele and no product for the knockout allele.
The targeted exon 1 of Lrig3 together with an untargeted region of Lrig3 (used as
the reference locus) were quantitated using a duplex ddPCR assay. The primers and
probes for ddPCR were purchased from Integrated DNA Technologies (Leuven,
Belgium). The ddPCR primers used were for Lrig3 exon 1: 5′-CGCCTTCCCGATC
CTCTC-3′ and 5′-GTCTCCTTCACCCCACCG-3′ and for the untargeted Lrig3
locus: 5′-AACCGTCACCAAGGGAGA-3′ and 5′-CCACCAAAGGGCTGTCATC-
3′. The probes used were for Lrig3 exon 1: FAM-conjugated 5′-ATACTGATACT
CACAGCCGTGTGACCCAGG-3′ and for the untargeted Lrig3 locus, HEX-
conjugated 5’-CATTGCTGGAGGGAGCCCGCCC-3′. The final concentrations of
forward and reverse primers were 400 nM, and the final concentrations of the
probes were 200 nM. DNA, ddPCR Supermix (with no dUTP) (Bio-Rad Labora-
tories AB, Stockholm, Sweden, catalog # 1863024), Hind III restriction enzyme
(Fisher Scientific GTF AB, FastDigest, catalog # FD0505), and nuclease-free water
were mixed with primer/probe sets of the targeted and untargeted regions of Lrig3.
Droplets were generated using a QX200 droplet generator followed by PCR using
a T100 thermal cycler (Bio-Rad Laboratories AB) with PCR parameters of 37°C
for 5 min, 95 °C for 5 min; 40 cycles of 30 s at 95 °C and 1min at 58 °C, followed by
98 °C for 10 min. After PCR amplification, the plate was loaded into the QX200
droplet reader (Bio-Rad Laboratories AB) to acquire the data. The data were
analyzed using QuantaSoft software (Bio-Rad Laboratories AB, version 1.7.4.0917).
Investigators were blinded to the cell line identities at the time of performing
ddPCR and data analysis.
Western blot analysis. Cells were lysed for 30 min on ice with cell extraction
buffer (Invitrogen, Fisher Scientific GTF AB) supplemented with cOmplete,
EDTA-free Protease Inhibitor (Roche Diagnostics Scandinavia AB, Bromma,
Sweden) and, when analyzing phosphorylated proteins, phosphatase inhibitor
PhosSTOP (Roche Diagnostics Scandinavia AB). The lysates were then centrifuged
at 20,800 x g for 10 min at 4°C. The resulting pellets were discarded. The protein
concentrations of the cleared lysates were determined using a Pierce BCA Protein
Assay Kit (Fisher Scientific GTF AB). The protein samples were separated through
polyacrylamide gel electrophoresis using 3-8% Tris-acetate gels or 10% Bis-Tris gels
(Invitrogen, Fisher Scientific GTF AB, catalog # EA03752 and NP0302, respec-
tively) and then electrotransferred onto polyvinylidene fluoride or nitrocellulose
membranes (Bio-Rad Laboratories AB). The membranes were then blocked with
Odyssey blocking buffer (LI-COR Biosciences GmbH, Bad Homburg, Germany) or
5% fat-free milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T). The blocked
membranes were incubated at 4°C overnight with the primary antibodies at the
indicated concentrations (Supplementary Table 10). After three washes with TBS-
T, the membranes were incubated with the appropriate secondary antibodies for an
hour at room temperature, followed by washes in TBS-T. Thereafter, immune-
reactive bands were visualized and analyzed using the Odyssey CLx imaging system
(LI-COR Biosciences GmbH) or ECL-select (GE Healthcare, Uppsala, Sweden)
together with the ChemiDoc Touch Imaging System (Bio-Rad Laboratories AB).
The primary and secondary antibodies used for Western blotting are listed in
Supplementary Table 10.
Cell proliferation assays. Cell proliferation rates were determined by direct cell
counting and an MTT assay. For cell counting, cells were seeded at a density of
2,800 cells per cm2 in TC 6-well standard plates (Sarstedt AB, Helsingborg, Swe-
den). The cells were trypsinized at different times after seeding and counted via the
use of a Countess Automated Cell Counter (Invitrogen, Fisher Scientific GTF AB).
For the MTT-assay, cells were seeded at the same density in TC 96-well standard
plates (Sarstedt AB). Twenty-four hours after the seeding, the medium was
changed to cell culture medium containing different FBS or PDGF-BB con-
centrations. Thereafter, the cells were incubated for an additional 48 h followed by
quantification of relative cell numbers via an MTT proliferation kit (Sigma-Aldrich
Sweden AB) according to the manufacturer’s instructions.
Cell migration assay. Migration assays were performed using Corning Transwell
cell culture plates with 6.5 mm inserts of 8 μm pore size (Fisher Scientific, GTF
AB). Five thousand cells were plated in the upper chamber with medium con-
taining, or not containing, 10% FBS in the bottom chamber. Twenty-four hours
after the plating, the membranes were washed with PBS, fixed in ice-cold methanol
for 20 min, and stained with 0.1% crystal violet in 20% methanol for 20 min. Five
fields from each chamber were counted manually using an Axio Vert.A1 inverted
microscope (Carl Zeiss AB, Stockholm, Sweden) equipped with a 5x objective.
Flow cytometry. For flow cytometry analyses, cells were dissociated using Accutase
cell detachment solution (Sigma-Aldrich, Sweden AB) and then washed in PBS
containing 5% FBS. For analysis of intracellular antigens, cells were fixated in 4%
phosphate-buffered formaldehyde for 10 min and then permeabilized using 0.2%
saponin from Quillaja bark (Sigma-Aldrich, Sweden AB) in PBS for 10 min. The
cells were labeled with primary antibodies for 30 min on ice, washed and then
incubated with secondary antibodies for 30 min on ice. The primary and secondary
antibodies used for flow cytometry analysis are listed in Supplementary Table 10.
The flow cytometry analyses were performed on a BD Accuri C6 instrument (BD
Biosciences).
Cell metabolism analyses. Cell metabolism was analyzed with a Seahorse XFe cell
analyzer (Agilent Technologies, Inc., Santa Clara, CA, USA) using the mito stress
test and glyco stress test assays according to the manufacturer’s instructions. In the
mito stress assay, the cells were sequentially treated with 1 μM oligomycin, 1 μM
FCCP, and 0.5 μM rotenone and antimycin A. After each treatment, the OCR was
measured at three time points. In the glycolytic stress test, the cells were glucose-
starved for 1 h followed by sequential treatments with 10 mM glucose, 1 μM oli-
gomycin, and 50 mM 2-deoxy-glucose. After each treatment, the ECAR was
measured at three time points. The measurements were normalized to the relative
cell numbers, which were determined through the measurement of cell nuclei
fluorescence after staining with Hoechst 34580 (Sigma-Aldrich Sweden AB), using
a Synergy2 microplate reader (BioTek Instruments SAS, Colmar Cedex, France).
In vitro adipogenesis assay. For adipogenic transformation, MEFs were seeded at
a density of 28,000 cells/cm2 at day −1. At day 0, cells were subjected to an initial
adipogenic cocktail containing 1 μM dexamethasone (Sigma-Aldrich Sweden AB),
0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich, Sweden AB), 10 μg/ml
bovine insulin in HEPES buffer (Sigma-Aldrich Sweden AB), and 16 μg/ml rosi-
glitazone (Sigma-Aldrich, Sweden AB). At day 2, the medium was thereafter
changed to a cocktail containing 10 μg/ml insulin and 16 μg/ml rosiglitazone and
was changed every two days until day 9 when the cells were fixed with 4% for-
maldehyde (Unimedic Pharma AB, Stockholm, Sweden) for 30 min and stained
using a 60% isopropanol solution with 0.5% Oil Red O (Sigma-Aldrich, Sweden
AB). In some experiments, 100 ng/ml recombinant murine noggin (PeproTech
Nordic, Stockholm, Sweden, catalog # 250-38) was added at day −1 or 50 ng/ml
recombinant human BMP4 (PeproTech Nordic, catalog # 120-05ET) was added at
day 0. The Oil Red O stained cells were quantified in a Spectramax i3x plate reader
(Molecular Devices, San Jose, CA, USA) using the Softmax Pro 7 software
(Molecular Devices).
RNA-extraction and quantitative RT-PCR-analyses. For qRT-PCR, RNA was
prepared using a PureLink RNA Mini Kit (Invitrogen, Fisher Scientific GTF AB)
followed by treatment with PureLink DNase (Invitrogen, Fisher Scientific GTF AB)
according to the manufacturer’s instructions. The TaqMan gene expression assays
for Lrig1 (Mm00456116_m1), Lrig3 (Mm00622766_m1), Cebpb (mm00843434_s1),
Pparg (mm00440940_m1), and Fabp4 (mm00445878_m1) were purchased from
Fisher Scientific GTF AB. Primers and probes for Lrig2 and RN18S have been
previously described1. Data were acquired using a CFX96 system C1000 thermal
cycler (Bio-Rad Laboratories AB) as previously described63. The specific gene
expression levels were normalized to that of RN18S by transforming the ΔCT values
from log2 to linear values.
Lipidomics. One million cells were trypsinized, washed with PBS, and then frozen
at −80 °C until use. Lipid extraction and liquid chromatography-quadrupole time-
of-flight mass spectrometry-based lipidomics analysis was performed at the
Swedish Metabolomics Centre at the Swedish University of Agricultural Sciences
(Umeå) as previously described64.
Luciferase reporter assays. Canonical BMP and TGFβ signaling was assessed by
transiently transfecting the indicated MEFs with pGL3-BRE-Luciferase65 (Addgene) or p
(CAGA)12MLP-Luc42 (kindly provided by Serhiy Souchelnytskyi, Ludwig Institute for
Cancer Research, Uppsala, Sweden), respectively. Transfections were performed with
Fugene 6 transfection reagent (Promega Biotech AB, Nacka, Sweden) according to the
manufacturer’s instructions using a 1:3 DNA:reagent ratio, with a DNA amount cor-
responding to 0.7 μg/cm2 and a reporter plasmid;Renilla reference plasmid ratio of 1:10.
Twenty-four hours after transfection, cells were starved for one hour and treated with
BMP4 or recombinant human TGF-β1 (PeproTech Nordic, catalog # 100-21) for three
hours. PDGF signaling was assessed using the stably transduced srf/elk-1 luciferaseMEF
lines. Here, the cells were serum-starved for one hour followed by treatment with
different concentrations of PDGF-BB (PeproTech Nordic, catalog # 315-18) for four
hours. After the treatments with growth factors, cells were lysed using a Dual-Glo
Luciferase Assay System (Promega Biotech AB) with a 20-minute incubation time for
both assay reagents. Plates were analyzed with a Glomax 96 microplate luminometer
(Promega Biotech AB) using an exposure time of 1 s per well. When analyzing transient
BMP and TGFβ reporters, the data were normalized by taking the ratio of luciferase/
Renilla. For the stably transduced srf/elk-1 reporter cells, only luciferase was used.
Phospho-Smad immunofluorescence and Western blot assays. To analyze
BMP- or TGFβ-induced phosphorylation of Smad1/5 and Smad3, respectively, cells
were seeded the day before stimulation in a 96-well cell culture microplate (Greiner
Bio-One International GmbH, Monroe, NC, USA, catalog # 655090) at densities of
3,000 cells per well for wild-type or Lrig-null MEFs, 1,800 cells per well for LRIG-
inducible MEFs, and 10,000 cells per well for HEK293T and A375 cells. LRIG
expression was induced in LRIG-inducible cells by treatment of the cells with 100
ng/ml, unless otherwise indicated, of doxycycline (Clontech Laboratories, Bio-
Nordika Sweden AB, Stockholm, Sweden) for 24 hours prior to starvation. Cells
were starved in serum-free cell culture medium for one hour and then stimulated
with BMP4, recombinant human BMP6 (PeproTech Nordic, catalog # 120-06),
recombinant human GDF2/BMP9 (PeproTech Nordic, catalog # 120-07), or TGF-
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-01613-w
12 COMMUNICATIONS BIOLOGY |            (2021) 4:90 | https://doi.org/10.1038/s42003-020-01613-w | www.nature.com/commsbio
β1 for one hour. Thereafter, the cells were fixed with 4% formaldehyde for 10 min,
permeabilized with 0.2% saponin for 10 min, and blocked in blocking buffer
composed of PBS, 0.1% Tween 20, and 5% FBS. After blocking, cells were incu-
bated overnight with the appropriate primary antibody followed by washes and an
incubation for one hour with the corresponding secondary fluorescent antibodies.
For cell number normalization, 1 μg/ml Hoechst 33342 was added before analysis.
Plates were imaged using a whole-well imaging device Trophos Plate Runner HD
(Trophos/Dioscure, Marseille, France) with exposure time set to detect stained
area. Images were analyzed using the Tina analysis package (Trophos/Dioscure)
adjusting the threshold to remove background and rolling ball subtraction. Objects
at specified sizes were detected, and their fluorescence was normalized using
Hoechst 33342 nuclear staining by dividing the number of cells (for MEFs and
A375 cells) or the mean cell fluorescence (for HEK293T cells). For Western blot
analysis, cells were seeded into 6-well plates at a density of 10,344 cells/cm2. Two
days after seeding, cells were starved for one hour in serum-free medium and then
stimulated with 5 or 20 ng/ml BMP4 or serum-free medium for one hour before
lysis. The antibodies used for the phospho-Smad immunofluorescence and Wes-
tern blot analyses are listed in Supplementary Table 10.
Transcriptomics. Transcriptomes were analyzed via RNAseq. To this end, 500,000
cells were serum-starved for 1 h prior to cell lysis. RNA was isolated using the
Dynabeads mRNA DIRECT Purification Kit (Fisher Scientific GTF AB) according to
the manufacturer’s instructions. The purity and integrity of the RNA preparations
were confirmed with an RNA 6000 Nano kit and an Agilent Bioanalyzer (Agilent
Technologies). Sequencing was performed at SciLifeLab (Uppsala, Sweden) with an
Ion Technology sequencer Ion Proton (Fisher Scientific GTF AB). Reads were aligned
using STAR and bowtie2 software, and HTSeq was used to generate counts.
Correlations between LRIG1-GFP variants and BMP-induced phosphorylation
of Smad1/5. Cells were transiently transfected using Fugene 6 as described above.
pLRIG1-GFP encoding full-length LRIG1 fused to GFP has been described, pre-
viously66. pLRIG1-Δcyto-GFP encoding the extracellular/luminal and transmem-
brane parts, together with the first three cytosolic amino acids (YQT), of LRIG1
fused to GFP was generated by cloning the corresponding PCR-amplified LRIG1
fragment into the pEGFP-N1 (Clontech Laboratories) expression vector. PCR was
used to generate pLRIG1-3XFLAG and pLRIG1-ecto-3XFLAG by amplifying the
regions corresponding to the full length and the ectodomain of LRIG1, respectively,
from an LRIG1 cDNA (GenBank accession no. AF381545) and cloning these
fragments into p3XFLAG-CMV-13 (Sigma-Aldrich Sweden AB). The integrity of
pLRIG1-3XFLAG and pLRIG1-ecto-3XFLAG were confirmed by DNA sequencing
using a Big Dye Terminator v 3.1 cycle sequencing kit (Fisher Scientific GTF AB)
and a 3730xl DNA analyzer (Fisher Scientific GTF AB). Twenty-four hours after
transfection, Smad1/5 phosphorylation immunofluorescence assays were per-
formed using 20 ng/ml BMP4 for 20 min. Both GFP fluorescence and pSmad1/5
immunofluorescence were quantified simultaneously using a Trophos plate runner.
RTK array. To compare the RTK phosphorylation levels, whole-cell lysates con-
taining 150 μg protein were analyzed using a Human Phospho-RTK Array Kit
(R&D Systems Europe Ltd., Abingdon, UK; catalog # ARY014) according to the
manufacturer’s instructions and quantified using ChemiDoc Touch Imaging Sys-
tem and Image lab software (Bio-Rad Laboratories AB).
C. elegans analyses. All C. elegans strains used are described in WormBase
(www.wormbase.org). N2 Bristol was used as the wild-type strain in all cases.
Worms were maintained at 20 °C on standard nematode growth medium (NGM)
agar and with E. coli OP50 as a food source. One-day-old adult worms from staged
plates were stained with Oil Red O as described previously67 and imaged at a
midplane, with the mouth and the pharyngeal lumen in focus, using the 10x
objective on a DIC-equipped Olympus BX51 microscope. Color images were then
subtracted for background (rolling ball radius: 50.0 pixels) and converted to 8-bit
CIELAB using Fiji software68. Quantifications were performed in the “a” channel
by selecting an area averaging ~2,500 μm2 between the posterior end of the
pharynx and the anterior border of the gonad to avoid the signal coming from the
oocytes. The local background signal for each measurement was then subtracted.
All genotypes under study were analyzed in parallel, and each experimental round
was normalized to the combined mean signal, which was calculated from all
genotype means.
Statistics and reproducibility of cell and animal experiments. All Student’s
t-tests were 2-sided. All statistical analyses of cell and animal experiments were
performed using GraphPad Prism 8 software (La Jolla, CA, USA), and the P-values
<0.05 were considered significant. When cell lines were compared, in general, data
were obtained from at least four biological replicates per genotype and three
experimental repeats performed on separate days. The exact number of replicates
are presented in the individual figure legends.
UK Biobank population characteristics. The UK Biobank is a large project with
genotyped and well-phenotyped individuals comprising approximately 500,000
participants69. In this study, we excluded participants who did not have BMI
measurements or of any of the other outcome variables of interest (done at the
stage of that particular analysis) and those who had ambiguous information on sex
(discordance between self-reported and genetically encoded sex). The final sample
size was 398,810 participants of Caucasian ancestry. Supplementary Table 3 shows
the participants’ characteristics, and Supplementary Table 4 shows the LRIG1 tag
SNP information. This study was conducted using publicly available data from the
UK Biobank, and therefore the current analyses did not require specific ethical
approval. The reference for the approved UK Biobank project is ukb18274.
Tag SNP identification. We used snptag, an online tool of SNPinfo,
(https://snpinfo.niehs.nih.gov/snpinfo/snptag.html) to identify tag SNPs from the
nine LRIG1 SNPs that were significant in the genome-wide association (GWA)
analysis. In our tag SNP selection, the population was restricted to the Utah
residents with Northern and Western European ancestry from the CEPH collection
(CEU); the linkage disequilibrium (LD) threshold was set at r2= 0.8, the maximum
distance (bp) between SNPs for calculating the LD was 250,000 bp, and the minor
allele frequency (MAF) range was 0.01 to 0.5. Three tag SNPs and one non-
synonymous SNP were identified from the search (Supplementary Fig. 6).
Association with type 2 diabetes and BMI. To isolate the effect of BMI attributed
to genetic variance, we regressed out the effects of age, age squared, sex, batch
effect, and the first ten genetic principal components separately for men and
women and extracted the BMI residuals. The residuals were then used in sub-
sequent analyses as (a) untransformed residuals, and, (b) as inverse-normal
transformed residuals. Each case is indicated in the respective analyses. We used
these transformed residuals to create interaction terms with each of the tag SNPs
and investigated the associations between these interaction terms and the risk of
type 2 diabetes for each of the SNPs using logistic regression models adjusted for
age, batch effect (array type used for genotyping, UK BiLEVE or UKBB Axiom)
and the first ten genetic principal components. Type 2 diabetes was diagnosed by a
doctor in this population and was parameterized as a binary outcome, coded “Yes”
or “No”, for these analyses. We also tested the association of each of the SNPs with
type 2 diabetes using logistic regression models adjusted for untransformed BMI
residuals and another model without BMI, in addition to the covariates mentioned
above in the first model. We investigated the relationship between BMI and each of
the SNPs using a simple linear regression model with untransformed BMI residuals
as the outcome. All analyses were based on an additive genetic model.
Association with liver fat and biochemical measures of adiposity. To investi-
gate the relationship between these tag SNPs and liver fat percentage (LF%) among
3,858 UK Biobank participants who had liver fat measurements, we extracted LF%
residuals separately in men and women using multiple linear regression models
adjusted for age, age squared, sex, BMI, array batch, and the first ten genetic
principal components. The residuals were then inverse-normal transformed, and a
simple linear regression model was fitted to test the association between each of the
SNPs with LF% residuals as an outcome. For each of the two biochemical measures
(baseline total cholesterol (mmol/L) and triglyceride levels (mmol/L)), we extracted
residuals for participants with the relevant measures as outlined above. Cholesterol
was normally distributed, so the residuals were not further transformed, but those
for triglycerides were inversely normal transformed. The association between each
of the measures and each of the tag SNPs was modeled using a simple linear
regression model with the respective residuals as the outcome. In all analyses, the
minor allele was used as the reference allele.
GENiAL study participants. The GENetics of Adipocyte Lipolysis (GENiAL)
cohort included 273 men and 718 women and have been described previously70.
Briefly, subjects in the GENiAL cohort were recruited by local advertisement to
examine the regulation of fat cell function. Fifty-seven percent of the participants
were obese (defined as BMI ≥ 30 kg/m2). They all lived in Stockholm County,
Sweden and were at least second-generation Swedes. One hundred ninety-four
participants had type 2 diabetes, hypertension, or dyslipidemia alone or in different
combinations. None were treated with insulin, glitazones, or glucagon-like-peptide
analogs. Data on clinical variables are summarized elsewhere70. The study was
approved by the local ethics committee at the Huddinge University Hospital
(D. no. 167/02, 2002-06-03) and was explained in detail to each participant.
Informed consent was obtained from all participants. Included in this study were
948 subjects from the GENiAL cohort with adipose morphology data available70.
Clinical examination. The GENiAL participants came to the hospital’s clinical
research center the morning after an overnight fast. Their heights, weights, and
waist-to-hip ratios (WHRs) were measured. Each participant’s body fat content was
measured by bioimpedance, and their total body fat mass was indirectly calculated
using a formula based on age, sex and BMI71. A venous blood sample was obtained
for extraction of DNA and clinical chemistry by the hospital’s accredited routine
clinical chemistry laboratory. Subcutaneous adipose tissue (SAT) was obtained by a
needle aspiration biopsy lateral to the umbilicus as previously described72.
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Adipose tissue phenotyping. SAT samples were rapidly rinsed in sodium chloride
(9 mg/ml) before removal of visual blood vessels and cell debris and were subse-
quently subjected to collagenase treatment to obtain isolated adipocytes as descri-
bed73. The mean weight and volume of remaining cells were determined as
described74. A curve fit of the relationship between mean adipocyte volume and
estimated abdominal subcutaneous fat mass was performed75. The difference between
the measured and expected mean adipocyte volume at the corresponding total fat
mass determines adipose morphology. If the measured adipocyte volume is larger
than expected, SAT hypertrophy prevails, whereas the opposite is true for hyperplasia.
Thus, this measure of adipose morphology is independent of total fat mass.
Genetic analysis of the GENiAL cohort. The genetic analysis of the GENiAL
cohort has been described previously70. After quality control, 894 samples were
available for analysis. Genetic association analysis was conducted in PLINK76,
using linear regression, assuming an additive genetic model, and adjusting for
population structure (PCs1-3), age, and sex.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The transcriptomic RNAseq datasets generated and analyzed during the current study are
available in the NCBI BioProject repository, https://www.ncbi.nlm.nih.gov/bioproject/
PRJNA684140. Relevant data and/or materials not present are available upon reasonable
request from C.He. (carl.herdenberg@umu.se) and/or H.H. (hakan.hedman@umu.se).
Source data from the UK Biobank are available upon approved application through the
UKBB data application management system. Source data for the main figures are
presented in Supplementary Data 1.
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